Eloxx Pharmaceuticals, Inc. Financial Flexibility Index
Eloxx Pharmaceuticals, Inc. financial flexibility index. Eloxx Pharmaceuticals, Inc. (ELOX) has a Financial Flexibility Index of -0.28x as of June 2026. Free cash flow of $-4.79 Million (operating CF $-4.79 Million minus capex $0.00) represents 0% of total liabilities ($16.97 Million). See cash generation quality of Eloxx Pharmaceuticals, Inc. to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Eloxx Pharmaceuticals, Inc. (2004–2025)
Financial flexibility index of Eloxx Pharmaceuticals, Inc. from 2004 to 2025. Historical Financial Flexibility Index trend for Eloxx Pharmaceuticals, Inc. across 22 annual periods. Explore debt repayment capacity of Eloxx Pharmaceuticals, Inc. to assess how comfortably operating cash covers total debt obligations.
Eloxx Pharmaceuticals, Inc. Financial Flexibility Index by Year (2004–2025)
Eloxx Pharmaceuticals, Inc. financial flexibility index by year from 2004 to 2025. Year-by-year free cash flow to debt coverage for Eloxx Pharmaceuticals, Inc.. For the full cash flow conversion analysis, see ELOX cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | $0.00 | $-6.33 Million | $17.18 Million | ▲ +100.0% |
| 2024 | -0.17x | $-4.71 Million | $-4.71 Million | $27.31 Million | ▲ +70.7% |
| 2023 | -0.59x | $-14.34 Million | $-14.34 Million | $24.31 Million | ▲ +41.0% |
| 2022 | -1.00x | $-31.78 Million | $-31.84 Million | $31.78 Million | ▲ +34.8% |
| 2021 | -1.53x | $-34.91 Million | $-35.00 Million | $22.75 Million | ▲ +11.5% |
| 2020 | -1.73x | $-28.17 Million | $-28.17 Million | $16.25 Million | ▼ -0.2% |
| 2019 | -1.73x | $-39.35 Million | $-39.39 Million | $22.73 Million | ▲ +56.6% |
| 2018 | -3.99x | $-31.13 Million | $-31.37 Million | $7.81 Million | ▲ +13.0% |
| 2017 | -4.59x | $-15.70 Million | $-15.94 Million | $3.42 Million | ▼ -482.0% |
| 2016 | -0.79x | $-3.68 Million | $-3.68 Million | $4.67 Million | ▲ +20.1% |
| 2015 | -0.99x | $-7.22 Million | $-7.34 Million | $7.32 Million | ▼ -18.5% |
| 2014 | -0.83x | $-4.86 Million | $-4.87 Million | $5.84 Million | ▲ +31.5% |
| 2013 | -1.21x | $-3.90 Million | $-3.90 Million | $3.21 Million | ▲ +5.7% |
| 2012 | -1.29x | $-4.38 Million | $-4.39 Million | $3.40 Million | ▲ +2.5% |
| 2011 | -1.32x | $-5.39 Million | $-5.39 Million | $4.08 Million | ▼ -65.2% |
| 2010 | -0.80x | $-4.74 Million | $-4.74 Million | $5.93 Million | ▲ +70.6% |
| 2009 | -2.72x | $-3.96 Million | $-3.96 Million | $1.45 Million | ▲ +8.6% |
| 2008 | -2.98x | $-2.40 Million | $-2.41 Million | $807.28K | ▲ +7.3% |
| 2007 | -3.21x | $-2.03 Million | $-2.03 Million | $632.21K | ▲ +26.0% |
| 2006 | -4.34x | $-2.53 Million | $-2.53 Million | $583.39K | ▼ -7.6% |
| 2005 | -4.03x | $-2.11 Million | $-2.12 Million | $523.39K | ▼ -2.5% |
| 2004 | -3.93x | $-1.89 Million | $-1.89 Million | $480.12K | — |